The "Fast Money" traders give you 5 names to trade as markets continue to hit new highs.
Jim Cramer saw eye popping signals that the global economy could be doing better than investors realize.
CNBC's Jim Cramer explains why he is keeping an eye on shares of Freeport-McMoRan.
Marc Faber, editor and publisher of "The Gloom, Boom and Doom Report" told CNBC there are some stocks worth owning in the face of a big bubble.
Brexit may torpedo any chance of a return to positive earnings growth for the S&P 500 for the year.
Jim Cramer says if this company listens to wise words of activist investor Nelson Peltz, it could be a winner.
SolarCity and Tesla seem to share little beyond grand ambitions, big cash outflows and large Musk stakes, Breakingviews says.
The "smart" money may be betting against a "Brexit" but harsh weather and asymmetric risk could be raining on investors' parade.
CNBC's Bob Pisani looks at "mass hypnosis" on Wall Street as the United Kingdom votes on the Brexit referendum.
Jim Cramer rattles off his take on caller favorite stocks, including this pharma stock that is ready to be sold.
Jim Cramer outlines what has prompted the staggering rally in energy prices, and what stands in the way of it going higher.
A handful of stocks have soared since the S&P 500 got off its February lows, but are these stocks really indicative of the broader market?
Discussing the commodity rally, with Boris Schlossberg, BK Asset Management, and Eddy Elfenbein, Crossing Wall Street.
The "Fast Money" traders discuss which trades they'd make at the market open.
The Fast Money traders share their final trades of the day.
CNBC's Deirdre Bosa uses Kensho data to check on a potential impact of falling copper prices.
Using Kensho, we looked at how the market and stocks performed when copper prices fell.
CNBC's Mary Thompson on the floor at the NYSE with what’s moving markets this morning.
Some of the names on the move ahead of the open.
The FMHR traders take their positions on four stocks making news today, including Bayer's bid for Monsanto and Freeport-McMoran cancelling its oil and gas business IPO.